H. De Koning

Cost-effectiveness of mammography screening.

G. V. Van Oortmarssen, R. Boer, H. De Koning, 1996, JAMA.

Swiss Medical Board Mammography screening predictions for Switzerland: Importance of time-periods

H. D. de Koning, H. De Koning, E. Heijnsdijk, 2015, Journal of medical screening.

Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands: comparison with the United Kingdom

P. J. van der Maas, R. Boer, R Boer, 1999, Journal of medical screening.

The effect of omitting an early population-based vision screen in the Netherlands: A micro-simulation model approach

E. Steyerberg, F. Sloot, F. Goudsmit, 2016, Journal of medical screening.

Cost-effectiveness of mammographic screening in Australia.

P. Glasziou, G. V. Oortmarssen, G. V. Van Oortmarssen, 2010, Australian journal of public health.

Stage distribution at first and repeat examinations in breast cancer screening

P. J. van der Maas, G. V. Van Oortmarssen, R. Boer, 1999, Journal of medical screening.

Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC).

A. Villers, E. Heijnsdijk, J. Hugosson, 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

MISCAN: estimating lead‐time and over‐detection by simulation

H. D. de Koning, G. Draisma, H. D. de Koning, 2003, BJU international.